| Code | 3726D | ||||||||||
| MA number | EU/1/20/1428/001 | ||||||||||
| Product Form: | sol inj 1x1 ml/189 mg (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU Orphan | ||||||||||
| MAH, country: | Alnylam Netherlands B.V, Netherland | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 02.03.2020 |
| Safety feature | Yes |
| Data update: | 04.12.2024 |
